In Kaposi’s sarcoma, prostate cancer, lung cancer and melanoma [17,58,59], it mimics the effect of vascular endothelial growth factor A (VEGFA) and confers resistance to anti-VEGF therapy [58]. This evidence concerns the gene VEGFA and Kaposi's sarcoma.